Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ignacio Conget, M. Sue Kirkman, Dachuang Cao, Mayme Wong, Jesus Reviriego & David M. Kendall. (2018) Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes. Current Medical Research and Opinion 34:2, pages 329-336.
Read now
Read now
Richard Simpson & Allen King. (2015) Can a fixed-ratio combination of insulin degludec and liraglutide help Type 2 diabetes patients to optimize glycemic control across the day?. Expert Review of Clinical Pharmacology 8:2, pages 179-188.
Read now
Read now
Articles from other publishers (19)
Abdulhamid Althagafi, Mohannad Alshibani, Samah O Alshehri, Afnan Barahim, Haneen Alghamdi, Dania Alaslani, Aisha Qari, Abdulaziz Almulhim & Ahmad Alamer. (2022) The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest Design Study. Cureus.
Crossref
Crossref
J. Ares-Blanco, P. Pujante-Alarcón, C. Lambert, P. Morales-Sánchez, E. Delgado-Álvarez & E.L. Menéndez-Torre. (2022) Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus. Revista Clínica Española (English Edition) 222:9, pages 516-522.
Crossref
Crossref
J. Ares-Blanco, P. Pujante-Alarcón, C. Lambert, P. Morales-Sánchez, E. Delgado-Álvarez & E.L. Menéndez-Torre. (2022) Efectos en vida real de la adición de semaglutida subcutánea semanal al tratamiento con insulina en diabetes mellitus tipo 2. Revista Clínica Española 222:9, pages 516-522.
Crossref
Crossref
Ashenafi Kibret Sendekie, Achamyeleh Birhanu Teshale & Yonas Getaye Tefera. (2022) Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia. PLOS ONE 17:5, pages e0268639.
Crossref
Crossref
J. Matthew Brennan, Martin B. Leon, Paige Sheridan, Isabel J. Boero, Qinyu Chen, Angela Lowenstern, Vinod Thourani, Sreekanth Vemulapalli, Kevin Thomas, Tracy Y. Wang & Eric D. Peterson. (2020) Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era. Journal of the American Heart Association 9:16.
Crossref
Crossref
Mark Warren & Donna Steel. (2020) Clinical Use of IDegLira: Initiation to Titration After Basal Insulin. Clinical Diabetes 38:1, pages 62-70.
Crossref
Crossref
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano & Katherine Esposito. (2019) The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice 154, pages 101-115.
Crossref
Crossref
E. Vonesh, K. L. Gooch, V. Khangulov, C. R. Schermer, K. M. Johnston, S. M. Szabo & J. S. Rumsfeld. (2018) Cardiovascular risk profile in individuals initiating treatment for overactive bladder – Challenges and learnings for comparative analysis using linked claims and electronic medical record databases. PLOS ONE 13:10, pages e0205640.
Crossref
Crossref
Anne Bijlsma-Rutte, Femke Rutters, Petra J.M. Elders, Sandra D.M. Bot & Giel Nijpels. (2018)
Socio-economic status and HbA
1c
in type 2 diabetes: A systematic review and meta-analysis
. Diabetes/Metabolism Research and Reviews 34:6, pages e3008.
Crossref
Crossref
Xiao-Wen Zhang, Xin-Lin Zhang, Biao Xu & Li-Na Kang. (2018) Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetologica 55:5, pages 429-441.
Crossref
Crossref
Tingting ZhangLinong JiYan GaoPuhong ZhangDongshan ZhuXian LiJiachao JiFang ZhaoHeng ZhangXiaohui Guo. (2017) Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors. Diabetes Technology & Therapeutics 19:11, pages 675-684.
Crossref
Crossref
Cheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, Gabriel Chodick & Avraham Karasik. (2017) Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study. Diabetes Therapy 8:5, pages 1047-1055.
Crossref
Crossref
Linong Ji, Puhong Zhang, Dongshan Zhu, Juming Lu, Xiaohui Guo, Yangfeng Wu, Xian Li, Jiachao Ji, Weiping Jia, Wenying Yang, Dajin Zou, Zhiguang Zhou, Yan Gao, Satish K. Garg, Changyu Pan, Jianping Weng & Sanjoy K. Paul. (2017) Comparative effectiveness and safety of different basal insulins in a real-world setting. Diabetes, Obesity and Metabolism 19:8, pages 1116-1126.
Crossref
Crossref
J.G. Kuiper, E.M. Heintjes, F.J.A. Penning-van Beest & R.M.C. Herings. (2017) Glykemische controle met basale insuline in vergelijking met DPP-4-remmers. Nederlands Tijdschrift voor Diabetologie 15:1, pages 5-10.
Crossref
Crossref
Philip Levin, Steve Zhou, Emily Durden, Amanda M. Farr, Jasvinder Gill & Wenhui Wei. (2016) Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs. Clinical Therapeutics 38:1, pages 110-121.
Crossref
Crossref
Linong JiPuhong ZhangJianping WengJuming LuXiaohui GuoWeiping JiaWenying YangDajin ZouZhiguang ZhouChangyu PanYan GaoXian LiDongshan ZhuYing LiYangfeng WuSatish K. Garg. (2015) Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China—Study Design and Baseline Characteristics. Diabetes Technology & Therapeutics 17:10, pages 735-744.
Crossref
Crossref
Simona Greco, Myriam Gorospe & Fabio Martelli. (2015) Noncoding RNA in age-related cardiovascular diseases. Journal of Molecular and Cellular Cardiology 83, pages 142-155.
Crossref
Crossref
Beverley Balkau, Françoise Calvi-Gries, Nick Freemantle, Maya Vincent, Valerie Pilorget & Philip D. Home. (2015) Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study. Diabetes Research and Clinical Practice 108:3, pages 432-440.
Crossref
Crossref
Marc Evans & Phil McEwan. (2015) Clinical and cost–effectiveness of insulin degludec: from clinical trials to clinical practice. Journal of Comparative Effectiveness Research 4:3, pages 279-286.
Crossref
Crossref